Related references
Note: Only part of the references are listed.Foxp3+ T Cells Induce Perforin-Dependent Dendritic Cell Death in Tumor-Draining Lymph Nodes
Alexandre Boissonnas et al.
IMMUNITY (2010)
The Macrophage Mannose Receptor Induces IL-17 in Response to Candida albicans
Frank L. van de Veerdonk et al.
CELL HOST & MICROBE (2009)
Signalling through C-type lectin receptors: shaping immune responses
Teunis B. H. Geijtenbeek et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Tumor-specific CD4+ T cells render the tumor environment permissive for infiltration by low-avidity CD8+ T cells
S. B. Justin Wong et al.
JOURNAL OF IMMUNOLOGY (2008)
Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation
Sven Burgdorf et al.
NATURE IMMUNOLOGY (2008)
Depletion of CD4+CD25+ human regulatory T cells in vivo:: Kinetics of Treg depletion and alterations in immune functions in vivo and in vitro
Karsten Mahnke et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Antigenic targeting of the human mannose receptor induces tumor immunity
Li-Zhen He et al.
JOURNAL OF IMMUNOLOGY (2007)
Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation
Sven Burgdorf et al.
SCIENCE (2007)
Mannose receptor expression and function define a new population of murine dendritic cells
Emma J. McKenzie et al.
JOURNAL OF IMMUNOLOGY (2007)
Depleting intratumoral CD4+CD25+ regulatory T cells via FasL protein transfer enhances the therapeutic efficacy of adoptive T cell transfer
Aoshuang Chen et al.
CANCER RESEARCH (2007)
The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation
Sven Burgdorf et al.
JOURNAL OF IMMUNOLOGY (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]
Vasso Apostolopoulos et al.
BREAST CANCER RESEARCH (2006)
Immunosuppressive networks in the tumour environment and their therapeutic relevance
WP Zou
NATURE REVIEWS CANCER (2005)
The mannose receptor: linking homeostasis and immunity through sugar recognition
PR Taylor et al.
TRENDS IN IMMUNOLOGY (2005)
Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules
V Ramakrishna et al.
JOURNAL OF IMMUNOLOGY (2004)
High and low affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin
C Galustian et al.
INTERNATIONAL IMMUNOLOGY (2004)
Defective CD8 T cell memory following acute infection without CD4 T cell help
JC Sun et al.
SCIENCE (2003)
The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells
A Engering et al.
JOURNAL OF IMMUNOLOGY (2002)
Cutting edge: Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo
C Kurts et al.
JOURNAL OF IMMUNOLOGY (2001)
Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses
V Apostolopoulos et al.
VACCINE (2000)
The cysteine-rich domain of the macrophage mannose receptor is a multispecific lectin that recognizes chondroitin sulfates A and B and sulfated oligosaccharides of blood group Lewisa and Lewisx types in addition to the sulfated N-glycans of lutropin
C Leteux et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Crystal structure of the cysteine-rich domain of mannose receptor complexed with a sulfated carbohydrate ligand
Y Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
TBH Geijtenbeek et al.
CELL (2000)
Share Paper
